Instem plc Innovators & Investors Forum (London)

TIDMINS

Instem plc

27 January 2015

Instem plc

("Instem" or the "Company")

Instem plc to exhibit at Innovators & Investors Forum - Tuesday 3 February 2015, London

Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that the Company will be exhibiting at the Innovators & Investors Forum on Tuesday 3 February at the Business Design Centre, London.

Instem's management team will be at their stand number 14 to answer any questions you might have and will be presenting to delegates in the Flowers Room at 3.15pm. No new material information will be disclosed during the course of the day.

Innovators & Investors Forum, sponsored by Cenkos and Shares magazine, is a one-day conference and exhibition which aims to showcase pioneering and imaginative technology-led firms and bring them together with the investment community. The event will run from 9.00am to 6.00pm with the conference agenda starting at 9.45am. For more information including registration details visit:

http://www.sharesmagazine.co.uk/events/event/iif2015/

For further information, please contact:

 
 Instem plc                                                          www.instem.com 
 Phil Reason, CEO                                         Tel: +44 (0) 1785 825 600 
 Nigel Goldsmith, CFO 
 
 N+1 Singer (Nominated Adviser                            Tel: +44 (0) 20 7496 3000 
  & Broker) 
 Richard Lindley 
 Nick Owen 
 
 Walbrook PR Ltd                 Tel: +44 (0) 20 7933 8780 or instem@walbrookpr.com 
 Bob Huxford                                               Mob: +44 (0)7747 635 908 
 Sam Allen                                                 Mob: +44 (0)7884 664 686

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with an additional location in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAFMGZMVVGGKZM

Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024